The largest database of trusted experimental protocols

5 protocols using cd34 antibody

1

CD34+ Cell Isolation and Bisulfite Pyrosequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary samples were incubated for 15 min in phosphate-buffered saline (PBS) with 2% fetal calf serum and CD34 antibody (BD Biosciences, UK). After washing in PBS (+2% fetal calf serum) and DAPI, samples were filtered through a cell strainer and transferred to FACs tubes. Then, samples were sorted using BD FACS Aria II cell sorter (BD Biosciences, UK) into CD34+ and CD34 cells. Bisulfite pyrosequencing was done as described (20 (link)) using the following primer sequences: forward, GGTTTTATTTAGGGTAGAGTAGATT; reverse (BIOTINYLATED), CCCCCTTCTTTCTATACCCAATACCATATC; sequencing primer, ACCAACTTACCCCAA.
+ Open protocol
+ Expand
2

Flow Cytometry and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD34 antibody (#555821) and CD38 antibody (#555460) for flow cytometry conjugated with biotin or specific dyes as required were purchased from BD Biosciences; γ-H2AX antibody was purchased from BioLegend (#613402). Western blot-related antibodies were purchased from Cell Signaling Technologies [GAPDH (#2118); BRCA1 (#9010); BRCA2 (#10741); DNA Damage Antibody Sampler Kit, (#9947); H2AX (#2595); CHK2 (#2662); ATM (#2873); ATR (#2790); Bcl2 (#15071) BIM (#2819); STAT3 (#9139); p-STAT3 (#9145)].
+ Open protocol
+ Expand
3

CML Mononuclear Cell Co-culture Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mononuclear cells from CML patients (Table 1) were stained with 5-(and 6-) carboxy-fluorescein diacetate succinimidyl ester (CFSE, Life Technologies, Carlsbad, CA) as described [51 (link)]. They were then co-cultured with MSCs in αMEM /10%FCS medium [13 (link)]. After proliferating (CFSEdim) and quiescent (CFSEbright) cells became distinguishable, cells were either stained with CD34 antibody (BD Biosciences, San Jose, CA) and sorted (BD FACSAriaTM II sorter, BD Biosciences) into proliferating or quiescent fractions [14 (link)] or treated with nutlin3a, ABT-737, nilotinib, nutlin3a plus ABT-737, or nutlin3a plus nilotinib (Table 1) with or without MSCs.
+ Open protocol
+ Expand
4

AML Cell Line and Primary Cell Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
SB415286 (SB) was obtained from Tocris Bioscience. Lithium, NBT, propidium iodide, 1,25D, SP600125, and noble agar were from Sigma-Aldrich. SB was used at 7.5 μmol/L, Lithium at 10mmol/L, and 1,25D at 5 nmol/L (low dose) or 25 nmol/L(high dose or unspecified). p-Serine, p-c-jun, actin, p-JNK, GSK3, p-MEK1/2, and p-p38 antibodies were obtained from Cell Signaling Technology. SRC3, cyclin A, and VDR antibodies were from Santa Cruz Biotechnology. P-208 VDR antibody was from Abcam. OCI-AML3 cells were obtained from DSMZ and 293T, HL-60, THP-1, Monomac-3, U937, and HeLa cells were obtained from ATCC (all cells were purchased in 2010). Upon receiving the cell lines, frozen stocks were prepared within 1 to 2 passages and new stocks were thawed frequently to keep the original condition. The cell lines were passaged for less than 6 months after receipt or resuscitation. They were also routinely authenticated on the basis of growth rate, morphology, and viability and were frequently confirmed to be mycoplasma-free.
Primary AML human bone marrow cells were obtained from the CWRU Hematopoietic Stem cell core facility. The AML samples that had fewer than 80% leukemic cells were purified by flow sorting (FACSAria) using CD34+ antibody (BD Biosciences). Guava ViaCount was obtained from Merck Millipore and used according to the manufacturer’s directions.
+ Open protocol
+ Expand
5

Isolation and Purification of Rhesus Macaque HSPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rhesus macaque PBMCs were isolated from PB using Ficoll-Paque PLUS density gradient medium (GE Healthcare) following manufacturer recommendations. G-CSF-mobilized (Amgen) and plerixafor-mobilized (Amgen) rhesus macaque CD34+ HSPCs were collected as described previously.29 (link),60 (link) In short, the animals were treated with a 5-day course of 15 μg/kg G-CSF (Amgen) subcutaneously and a single subcutaneous dose of 1 mg/kg AMD3100 (Sigma-Aldrich) on the morning of the fifth day, 3–4 h before leukapheresis. A small-volume leukapheresis procedure was performed using a CS3000 cell separator (Baxter Fenwal), and CD34+ HSPCs were immunoselected using a rhesus macaque CD34+ antibody (clone 12.8, Fred Hutchinson Cancer Research Center) and an anti-mouse IgM bead (Miltenyi Biotech). A CD34+ antibody (550761, BD Biosciences) was used to determine the purity of the immunoselected population.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!